Interestingly, in Alzheimer’s disease, acetylation of GSK3β at residue K15 (the equivalent of TgGSK K13) leads to the over-activation of the kinase, leading to the hyperphosphorylation of tau (36). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.